Iradimed reports Q2 revenue $20.5M, EPS $0.41; raises dividend to $0.20 and reaffirms 2026 guidance

Iradimed reported Q2 revenue of $20.5 million and GAAP diluted EPS of $0.41 while declaring a $0.20 quarterly dividend.Key Highlights:Original SEC Filing: IRADIMED CORP [ IRMD ] - 8-K - Jul. 31, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information…

Iradimed reported Q2 revenue of $20.5 million and GAAP diluted EPS of $0.41 while declaring a $0.20 quarterly dividend.

Key Highlights:

Q2 revenue was $20.5M, up $0.1M (0.5%) year-over-year; six-month revenue rose to $42.4M (+6%).
GAAP diluted EPS $0.41 and non-GAAP diluted EPS $0.46 for Q2; six-month GAAP EPS $0.86, non-GAAP $0.95.
Declared regular quarterly cash dividend of $0.20 per share, payable Aug 28, 2026 to holders of record Aug 14, 2026.
Company launched production ramp of next-gen 3870 MR IV pump; expects revenues and efficiency gains to ramp in H2 2026.
Reaffirmed Q3 revenue guidance $23.0M–$24.5M and full-year 2026 revenue guidance $91.0M–$96.0M with GAAP EPS $1.90–$2.05.

Original SEC Filing:

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.